2020
DOI: 10.1007/s40005-020-00499-4
|View full text |Cite
|
Sign up to set email alerts
|

Recent advances of nanocellulose in drug delivery systems

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
60
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 90 publications
(60 citation statements)
references
References 141 publications
0
60
0
Order By: Relevance
“…Further issues for bacterial cellulose as a drug delivery material revolve around the difficulty in modulating drug release, and irregular loading patterns of pharmaceuticals. Improved protocols and the development of novel processing techniques should be explored in order to overcome these issues which currently impede the widespread use of bacterial cellulose as a biomedical material [ 145 ].…”
Section: Limitations and Future Advancementsmentioning
confidence: 99%
“…Further issues for bacterial cellulose as a drug delivery material revolve around the difficulty in modulating drug release, and irregular loading patterns of pharmaceuticals. Improved protocols and the development of novel processing techniques should be explored in order to overcome these issues which currently impede the widespread use of bacterial cellulose as a biomedical material [ 145 ].…”
Section: Limitations and Future Advancementsmentioning
confidence: 99%
“…We anticipated that γCDP-(DMA/PEG-Tf) NPs with γCD pores (for host–guest interaction), pH-responsive cleavable DMA [ 22 , 23 ], and Tf (for Tf-mediated tumor endocytosis) [ 2 , 6 , 25 , 26 , 27 ] would provide a novel route for multifunctional tumor treatment [ 37 , 38 , 39 , 40 ]. Accordingly, we hypothesized that TPT drugs entrapped in the particles endocytosed to Tf-receptor positive tumor cells could be explosively released as a result of ionic repulsion between TPT and DMA-detached γCDP at endosomal pH, which in turn would enable cytosolic TPT release ( Figure 1 a).…”
Section: Resultsmentioning
confidence: 99%
“…Nanocellulose has a large surface-area-to-volume ratio, thus enabling more significant adsorption and therapeutic drug-binding capacity than other materials. With these properties, nanocellulose can facilitate drug release mechanisms and allocate drug delivery precisely to the target to drastically reduce drug consumption, leading to improved drug delivery system effectiveness [ 16 , 17 ]. Nanocellulose additionally exhibits other attractive characteristics such as stiffness, high mechanical strength, biocompatibility, low toxicity, lightweight, tunable surface chemistry, and renewability [ 11 , 18 ], which are desirable for the design of advanced drug delivery system.…”
Section: Introductionmentioning
confidence: 99%
“…Nanocellulose has been manufactured on the laboratory and industrial scale, i.e., ranging from 140 g day −1 to 50 ton year −1 in three different forms as nanocrystalline cellulose (NCC), nanofiber cellulose (NFC), and bacterial nanocellulose (BNC) [ 20 ]. Several recent research and review articles have comprehensively overviewed the process, extraction, characterization, and applications of nanocellulose and their modified structures in drug delivery systems [ 12 , 17 , 21 , 22 , 23 , 24 ].…”
Section: Introductionmentioning
confidence: 99%